home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Investor relations
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
Menu
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
press releases
11/15/2023
PainReform Provides Business Update for the Third Quarter of 2023
read more
09/11/2023
PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trialto Evaluate PRF-110 in Patients Undergoing Bunionectomy SurgeryFollowing Positive FDA Review of Drug Master File
read more
09/07/2023
PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, Hungary
read more
09/05/2023
PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York City
read more
08/10/2023
PainReform Provides Business Update for the Second Quarter of 2023
read more
07/12/2023
PainReformAnnounces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
read more
